Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, January 8, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Yi Chen Maintained (ANGO) at Strong Buy with Decreased Target to $18 on, Jan 8th, 2024
Yi Chen of HC Wainwright & Co., Maintained "AngioDynamics, Inc." (ANGO) at Strong Buy with Decreased Target from $20 to $18 on, Jan 8th, 2024.
Yi has made no other calls on ANGO in the last 4 months.
There are 2 other peers that have a rating on ANGO. Out of the 2 peers that are also analyzing ANGO, 0 agree with Yi's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Yi
- Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $12 on, Friday, October 6th, 2023
- William Plovanic of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $17 on, Thursday, October 5th, 2023
